Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surgical Management and Therapeutic Strategy of Uterine Sarcoma According to Histological Subtype and Staging: Updated Review and Recommendations.

Cancers·2026

Same author

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases: a scoping review of clinical evidence across emerging indications.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Same author

ASO Visual Abstract: Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma Surgery.

Annals of surgical oncology·2026

Same author

ASO Visual Abstract: Protective Effect of Diuresis During Hyperthermia on Acute Kidney Injury in Cytoreductive Surgery with HIPEC.

Annals of surgical oncology·2026

Same author

Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma Surgery.

Annals of surgical oncology·2026

Same author

ASO Author Reflections: Enhanced Recovery in Retroperitoneal Sarcoma Surgery-From Concept to Consensus.

Annals of surgical oncology·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Diagnostic Delay in Soft Tissue Sarcomas: A Review.

Juan Ángel Fernández^1,2, Beatriz Gómez¹, Daniel Díaz-Gómez³

¹Department of General Surgery, Hospital Universitario Los Arcos del Mar Menor, 30739 Murcia, Spain.

|June 13, 2025

Summary

Diagnostic delay in soft tissue sarcomas is common due to a lack of awareness, leading to negative consequences. Improving clinical referral guidelines is crucial for earlier detection and better patient outcomes.

Keywords:

2WW conversion rate delay detection rate diagnosis fast-track guideline litigation non-planned resections pathway prognosis red flag referral soft tissue sarcoma

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Jun 16, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

Area of Science:

Oncology
Diagnostic Imaging
Healthcare Management

Background:

Soft tissue sarcomas (STS) frequently experience diagnostic delays.
These delays stem from a general lack of knowledge and awareness regarding STS.
The consequences of delayed diagnosis are significant, impacting prognosis, medico-legal aspects, and psychosocial well-being.

Purpose of the Study:

To identify the causes and consequences of diagnostic delay in soft tissue sarcomas.
To understand clinical suspicion and referral pathways for STS.
To evaluate the limitations of current referral guidelines for STS.

Main Methods:

A systematic literature review was conducted.
The review focused on theoretical frameworks, key elements, causes, consequences, red flag symptoms, and existing referral guidelines.
Methods for avoiding excessive referrals were also examined.

Main Results:

Diagnostic delay in soft tissue sarcomas is frequent and poorly understood, with serious repercussions.
Current referral guidelines, primarily based on clinical data, have yielded disappointing results.
New strategies are needed, including improved imaging, diagnostic triage, and telemedicine, to enhance detection rates.

Conclusions:

Healthcare systems must investigate the extent and causes of diagnostic delays in STS.
Early referral is complex due to non-specific symptoms, necessitating guideline modification.
Enhanced detection and conversion rates require updated clinical referral guidelines for soft tissue sarcomas.